Diagnosis and management of complicated gout

Bulletin on the Rheumatic Diseases

Volumn 47, Issue 4, 1998, Pages 2-5

  Wise, Christopher M ^a   Agudelo, Carlos A ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; COLCHICINE; CORTICOTROPIN; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROBENECID; SULFINPYRAZONE; TRIAMCINOLONE; URATE; URICOSURIC AGENT; XANTHINE OXIDASE INHIBITOR;

DIFFERENTIAL DIAGNOSIS; FOLLOW UP; GOUT; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; TREATMENT PLANNING; URIC ACID BLOOD LEVEL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLCHICINE; GOUT; GOUT SUPPRESSANTS; HUMANS;

EID: 0031814892     PISSN: 00075248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Wallace SJ, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu T-F: Preliminary criteria for the classification of acute arthritis of primary gout. Arthritis Rheum 20:895-900, 1977.
2. Agudelo CA, Weinberger A, Schumacher HR, Turner R, Molina J: Definitive diagnosis of gout by identification of urate crystals in asymptomatic metatarsophalangeal joints. Arthritis Rheum 22:559-560, 1979.
3. Raddatz DA, Mahowald ML, Bilka PJ: Acute polyarticular gout. Ann Rheum Dis 42:117-120, 1983.
4. Emmerson BT: The management of gout. N Engl J Med 334:445-451, 1996.
5. Roberts WN, Liang MH, Stern SH: Colchicine in acute gout: reassessment of risks and benefits. JAMA 257:1920-1922, 1987.
6. Wallace SL, Singer JZ: Systemic toxicity associated with the intravenous administration of colchicine. Guidelines for use. J Rheumatol 15:495-499, 1988.
7. Fam AG: Current therapy of acute microcrystalline arthritis and the role of corticosteroids. J Clin Rheumatol 3:35-40, 1997.
8. Yu T-F: The efficacy of colchicine prophylaxis in articular gout. A reappraisal after 20 years. Semin Arthritis Rheum 12:256-264, 1982.
9. Wallace SL, Singer JZ, Duncan GJ, Wigley FM, Kund RW: Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout. J Rheumatol 18:264-269, 1992.
10. Wyngaarden JB, Kelly WN: Gout and Hyperuricemia. New York, Grune and Stratton, 1976.
11. Scott JT, Higgins CS: Diuretic induced gout: a multifactorial condition. Ann Rheum Dis 51:259-261, 1992.
12. Bull PW, Scott JT: Intermittent control of hyperuricemia in the treatment of gout. J Rheumatol 16:1246-1248, 1989.
13. Hande KR, Noone RM, Stone WJ: Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med 76:47-56, 1984.